| LFCR Stock | | | 7.46 0.15 2.05% |
Lifecore Biomedical employs about 524 people. The company is managed by 14 executives with a total tenure of roughly 1223 years, averaging almost 87.0 years of service per executive, having 37.43 employees per reported executive. Discussion of Lifecore Biomedical's management performance can provide insight into the enterprise performance.
Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifecore Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in main economic indicators.
To learn how to invest in Lifecore Stock, please use our
How to Invest in Lifecore Biomedical guide.
Lifecore Biomedical Management Team Effectiveness
The company has return on total asset
(ROA) of
(0.0225) % which means that it has lost $0.0225 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
0.1729 %, meaning that it created $0.1729 on every $100 dollars invested by stockholders. Lifecore Biomedical's management efficiency ratios could be used to measure how well Lifecore Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/26/2024,
Return On Tangible Assets is likely to drop to -0.02. In addition to that,
Return On Capital Employed is likely to drop to 0.02. At this time, Lifecore Biomedical's
Non Currrent Assets Other are relatively stable compared to the past year. As of 11/26/2024,
Total Current Assets is likely to grow to about 86.2
M, while
Non Current Assets Total are likely to drop slightly above 161.8
M.
As of 11/26/2024,
Common Stock Shares Outstanding is likely to drop to about 26.4
M. In addition to that,
Net Loss is likely to grow to about (87.4
M)
Lifecore Biomedical Workforce Comparison
Lifecore Biomedical is rated
fourth overall in number of employees category among its peers.
The total workforce of
Health Care industry is now estimated at about 23,799. Lifecore Biomedical holds roughly 524 in number of employees claiming about 2.2% of equities under Health Care industry.
Lifecore Biomedical Profit Margins
The company has Profit Margin (PM) of
0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of
(0.37) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.37.
Lifecore Biomedical Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific
Lifecore Biomedical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Lifecore Biomedical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Lifecore Biomedical insiders must file a Form 4 with the U.S.
Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Lifecore Biomedical Notable Stakeholders
A Lifecore Biomedical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Lifecore Biomedical often face trade-offs trying to please all of them. Lifecore Biomedical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Lifecore Biomedical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
The success or failure of an entity such as Lifecore Biomedical often depends on how effective the management is. Lifecore Biomedical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's
future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Lifecore management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Lifecore management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important
fundamental indicators such as return on assets and return on equity.
Traditionally, organizations such as Lifecore Biomedical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Lifecore Biomedical within its industry.
When running Lifecore Biomedical's price analysis, check to
measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to
predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.